Cargando…
Serum Albumin Before CRRT Was Associated With the 28- and 90-Day Mortality of Critically Ill Patients With Acute Kidney Injury and Treated With Continuous Renal Replacement Therapy
Introduction: Although low serum albumin (ALB) may worsen acute kidney injury (AKI), additional study is needed to establish the connection between ALB and the prognosis of critically ill patients with AKI and treated with continuous renal replacement therapy (CRRT). Methods:A secondary analysis of...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8425552/ https://www.ncbi.nlm.nih.gov/pubmed/34513902 http://dx.doi.org/10.3389/fnut.2021.717918 |
_version_ | 1783749869411762176 |
---|---|
author | Lv, Junhua Wang, Hai Sun, Baoni Gao, Yanxia Zhang, Zhenglinag Pei, Honghong |
author_facet | Lv, Junhua Wang, Hai Sun, Baoni Gao, Yanxia Zhang, Zhenglinag Pei, Honghong |
author_sort | Lv, Junhua |
collection | PubMed |
description | Introduction: Although low serum albumin (ALB) may worsen acute kidney injury (AKI), additional study is needed to establish the connection between ALB and the prognosis of critically ill patients with AKI and treated with continuous renal replacement therapy (CRRT). Methods:A secondary analysis of a bi-center, retrospective, and observational study, such as critically ill patients with AKI and treated with CRRT from January 2009 to September 2016. The univariate analysis, multi-factor regression analysis, sensitivity analysis, and curve-fitting analysis were applied to explore the association of ALB with the 28 and 90 days mortality of critically ill patients with AKI and treated with CRRT, and the removal efficiency of serum phosphorus. Results: From January 2009 to September 2016, 1,132 cases with AKI and treated with CRRT met the inclusion criteria and enrolled in this study. We found that the higher ALB before CRRT, the lower the 28- and 90-day mortality of patients with AKI and treated with CRRT, the higher removal efficiency of serum phosphorus, the adjusted hazard ratio (HR) value for 28-day mortality in the four models were separately 0.92 (0.90, 0.95), 0.91 (0.89, 0.94), 0.92 (0.89, 0.95), and 0.92 (0.89, 0.95); the adjusted HR value for 90 day mortality in the four models were 0.91 (0.89, 0.94), 0.92 (0.89, 0.95), 0.92 (0.89, 0.95), and 0.92 (0.89, 0.96); the adjusted OR value for the removal efficiency of serum phosphorus in the four models were separately −0.04 (−0.07, −0.01), −0.05 (−0.08, −0.01), −0.04 (−0.08, −0.01), and −0.04 (−0.08, −0.01). The sensitivity analysis and curve-fitting analysis also showed that ALB before CRRT was correlated with the 28 and 90 days mortality of critically ill patients with AKI and treated with CRRT and the removal efficiency of serum phosphorus. Conclusion: The higher the serum ALB before CRRT, the lower the mortality of critically ill patients with AKI and treated with CRRT, and the higher the clearance efficiency of serum phosphorus. |
format | Online Article Text |
id | pubmed-8425552 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-84255522021-09-09 Serum Albumin Before CRRT Was Associated With the 28- and 90-Day Mortality of Critically Ill Patients With Acute Kidney Injury and Treated With Continuous Renal Replacement Therapy Lv, Junhua Wang, Hai Sun, Baoni Gao, Yanxia Zhang, Zhenglinag Pei, Honghong Front Nutr Nutrition Introduction: Although low serum albumin (ALB) may worsen acute kidney injury (AKI), additional study is needed to establish the connection between ALB and the prognosis of critically ill patients with AKI and treated with continuous renal replacement therapy (CRRT). Methods:A secondary analysis of a bi-center, retrospective, and observational study, such as critically ill patients with AKI and treated with CRRT from January 2009 to September 2016. The univariate analysis, multi-factor regression analysis, sensitivity analysis, and curve-fitting analysis were applied to explore the association of ALB with the 28 and 90 days mortality of critically ill patients with AKI and treated with CRRT, and the removal efficiency of serum phosphorus. Results: From January 2009 to September 2016, 1,132 cases with AKI and treated with CRRT met the inclusion criteria and enrolled in this study. We found that the higher ALB before CRRT, the lower the 28- and 90-day mortality of patients with AKI and treated with CRRT, the higher removal efficiency of serum phosphorus, the adjusted hazard ratio (HR) value for 28-day mortality in the four models were separately 0.92 (0.90, 0.95), 0.91 (0.89, 0.94), 0.92 (0.89, 0.95), and 0.92 (0.89, 0.95); the adjusted HR value for 90 day mortality in the four models were 0.91 (0.89, 0.94), 0.92 (0.89, 0.95), 0.92 (0.89, 0.95), and 0.92 (0.89, 0.96); the adjusted OR value for the removal efficiency of serum phosphorus in the four models were separately −0.04 (−0.07, −0.01), −0.05 (−0.08, −0.01), −0.04 (−0.08, −0.01), and −0.04 (−0.08, −0.01). The sensitivity analysis and curve-fitting analysis also showed that ALB before CRRT was correlated with the 28 and 90 days mortality of critically ill patients with AKI and treated with CRRT and the removal efficiency of serum phosphorus. Conclusion: The higher the serum ALB before CRRT, the lower the mortality of critically ill patients with AKI and treated with CRRT, and the higher the clearance efficiency of serum phosphorus. Frontiers Media S.A. 2021-08-25 /pmc/articles/PMC8425552/ /pubmed/34513902 http://dx.doi.org/10.3389/fnut.2021.717918 Text en Copyright © 2021 Lv, Wang, Sun, Gao, Zhang and Pei. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Nutrition Lv, Junhua Wang, Hai Sun, Baoni Gao, Yanxia Zhang, Zhenglinag Pei, Honghong Serum Albumin Before CRRT Was Associated With the 28- and 90-Day Mortality of Critically Ill Patients With Acute Kidney Injury and Treated With Continuous Renal Replacement Therapy |
title | Serum Albumin Before CRRT Was Associated With the 28- and 90-Day Mortality of Critically Ill Patients With Acute Kidney Injury and Treated With Continuous Renal Replacement Therapy |
title_full | Serum Albumin Before CRRT Was Associated With the 28- and 90-Day Mortality of Critically Ill Patients With Acute Kidney Injury and Treated With Continuous Renal Replacement Therapy |
title_fullStr | Serum Albumin Before CRRT Was Associated With the 28- and 90-Day Mortality of Critically Ill Patients With Acute Kidney Injury and Treated With Continuous Renal Replacement Therapy |
title_full_unstemmed | Serum Albumin Before CRRT Was Associated With the 28- and 90-Day Mortality of Critically Ill Patients With Acute Kidney Injury and Treated With Continuous Renal Replacement Therapy |
title_short | Serum Albumin Before CRRT Was Associated With the 28- and 90-Day Mortality of Critically Ill Patients With Acute Kidney Injury and Treated With Continuous Renal Replacement Therapy |
title_sort | serum albumin before crrt was associated with the 28- and 90-day mortality of critically ill patients with acute kidney injury and treated with continuous renal replacement therapy |
topic | Nutrition |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8425552/ https://www.ncbi.nlm.nih.gov/pubmed/34513902 http://dx.doi.org/10.3389/fnut.2021.717918 |
work_keys_str_mv | AT lvjunhua serumalbuminbeforecrrtwasassociatedwiththe28and90daymortalityofcriticallyillpatientswithacutekidneyinjuryandtreatedwithcontinuousrenalreplacementtherapy AT wanghai serumalbuminbeforecrrtwasassociatedwiththe28and90daymortalityofcriticallyillpatientswithacutekidneyinjuryandtreatedwithcontinuousrenalreplacementtherapy AT sunbaoni serumalbuminbeforecrrtwasassociatedwiththe28and90daymortalityofcriticallyillpatientswithacutekidneyinjuryandtreatedwithcontinuousrenalreplacementtherapy AT gaoyanxia serumalbuminbeforecrrtwasassociatedwiththe28and90daymortalityofcriticallyillpatientswithacutekidneyinjuryandtreatedwithcontinuousrenalreplacementtherapy AT zhangzhenglinag serumalbuminbeforecrrtwasassociatedwiththe28and90daymortalityofcriticallyillpatientswithacutekidneyinjuryandtreatedwithcontinuousrenalreplacementtherapy AT peihonghong serumalbuminbeforecrrtwasassociatedwiththe28and90daymortalityofcriticallyillpatientswithacutekidneyinjuryandtreatedwithcontinuousrenalreplacementtherapy |